Global Cardiac Resynchronization Therapy Market
Global Cardiac Resynchronization Therapy Markets Analysis & Forecasts Report 2017-2021 & 2022-2030 Featuring Abbott, Boston Scientific, Medtronic, Biotronik Se & Co, & Microport Scientific
04 mars 2022 04h48 HE | Research and Markets
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Cardiac Resynchronization Therapy Market Size, Share & Trends Analysis Report by Product (CRT-defibrillator, CRT-pacemaker), by End User...
Global Intracranial Aneurysm Market
$1.2 Bn Intracranial Aneurysm Market (2021 to 2026) by Type, Condition, Treatment Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19
25 févr. 2022 05h13 HE | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Intracranial Aneurysm Market (2021-2026) by Type, Condition, Treatment Type, End-User, Geography, Competitive Analysis and the Impact of...
NovaSignal Logo.png
New Data Demonstrate NovaGuide™ Intelligent Ultrasound Significantly Improves Detection of Right-to-Left Shunt
11 févr. 2022 12h30 HE | NovaSignal Corporation
Clinical trial results show NovaGuide™ is three times more likely to detect RLS than transthoracic echocardiography Data presented in late-breaking science session at International Stroke Conference...
HYEX logo for newswire 1.png
Healthy Extracts Celebrates American Heart Month with New Video Series featuring “America’s Healthy Heart Doc,” Joel Kahn, Discussing Cardiovascular Health and Natural Ways to Improve Health
03 févr. 2022 08h31 HE | Healthy Extracts Inc.
LAS VEGAS, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched a new video...
22157.jpg
The Worldwide Neurology Patient Monitoring Industry is Expected to Reach $7.4 Billion by 2030
26 janv. 2022 07h43 HE | Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Neurology Patient Monitoring Market Size, Share & Trends Analysis Report by Application (Trauma, CSF Management, Migraine, Stroke, Hydrocephalus,...
Early Evaluation of
Early Evaluation of Transcarotid Artery Revascularization (TCAR) Versus Carotid Endarterectomy (CEA) Cost-Effectiveness
27 déc. 2021 08h15 HE | Society for Vascular Surgery
Rosemont, Ill., Dec. 27, 2021 (GLOBE NEWSWIRE) -- A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR)...
Algernon Logo 1.png
Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2
08 déc. 2021 07h04 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical...
Algernon Logo 1.png
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study
19 nov. 2021 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) a clinical stage pharmaceutical...
Algernon Logo 1.png
Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study
13 oct. 2021 07h00 HE | Algernon Pharmaceuticals
VANCOUVER, British Columbia, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
NovaSignal logo.png
NovaSignal Secures $37 Million in Series C1
28 sept. 2021 09h07 HE | NovaSignal Corporation
LOS ANGELES, Sept. 28, 2021 (GLOBE NEWSWIRE) -- NovaSignal Corp., a medical technology and data company specializing in the assessment and management of brain health, announced today it has closed...